Amneal Pharmaceuticals (AMRX) News
NASDAQ: AMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
19.91+0.26 (+1.32%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
AMRX news summary
We found 2 recent headlines mentioning Amneal Pharmaceuticals (AMRX): 1 in the past week and 1 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, AMRX is up 1.32% at $19.91. The most recent story, "Amneal to Report Third Quarter 2026 Results on November 3, 2026", was published by GlobeNewswire on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Amneal Pharmaceuticals headlines
- Amneal to Report Third Quarter 2026 Results on November 3, 2026BRIDGEWATER, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced it will report third quarter 2026 financial results on…GlobeNewswire
- ARGX Announces Positive Phase III Data on Vyvgart Hytrulo, Stock Upargenx's shares jump 16% as Vyvgart Hytrulo delivered positive phase III ALKIVIA data, supporting its potential label expansion in autoimmune myositis.NasdaqARGX, ACIU, AMRX, PGEN